From: Identification of genetic variants for clinical management of familial colorectal tumors
Patient_ID | Gender | ICD9 diagnosis (age) | AMS criteria | Revised Bethesda | Tumor molecular characteristics |
---|---|---|---|---|---|
3222 | F | CC (54), Hyperplastic polyp (55/61/62/63/65), BC (70) | 0 | Y | MMR IHC proficient |
3308 | F | CC (43), BC (51/52) | 0 | Y | MMR IHC proficient |
3387 | F | BC (40), OC (70), CC (80) | 0 | Y | MMR IHC proficient |
3426 | M | MM (39) | I & II | Y | na |
4932 | F | CC (34), EC (40), Hyperplastic polyp (43), BT (46) | I & II | Y | na |
5324 | F | M (52), CC (59), SMC (na), BC (72) | 0 | Y | na |
6174 | F | Hyperplastic polyp (63/67), BC (65) | I & II | Y | MMR IHC proficient |
6977 | F | TC (66) | 0 | Y | MMR IHC proficient |
9876 | F | M (45), BC (54) | 0 | Y | na |
9998 | F | Hyperplastic polyp (45), CC (45) | II | Y | MMR IHC proficient |
10,675 | F | BC (51), Hyperplastic polyp (59), TC (60) | II | Y | na |
12,954 | F | Hyperplastic polyp (69), ML (70) | II | Y | na |
13,072 | M | Hyperplastic polyp (63/64/65), CC (65/67) | 0 | Y | na |
14,930 | F | Hyperplastic polyp (86), CC (86) | 0 | Y | MMR IHC proficient |
18,843 | F | BC (44), CC (49), SMC (na) | 0 | Y | na |
19,411 | M | PC (70) | 0 | Y | MSH6 IHC deficient |
19,673 | F | BC (40/42) | II | Y | na |
20,612 | F | Hyperplastic polyp (59/65), EC (70) | 0 | Y | na |
21,368 | F | OC (62) | 0 | Y | na |
22,295 | F | Hyperplastic polyp (53), M (58) | 0 | Y | na |
23,761 | F | Hyperplastic polyp (40/42/44), BC (50) | 0 | Y | na |
23,910 | F | M (43), Hyperplastic polyp (49), BC (63), BT (63) | 0 | Y | na |
24,140 | F | CC (45/67), BC (56) | 0 | Y | na |
24,447 | F | BC (57/66), CC (66) | 0 | Y | MLH1/PMS2 IHC deficient and MSI |
11,705 | F | THC (53), KC (53/63) | II | Y | MMR IHC proficient |
12,673 | F | OC (23), SMC (36), RC (62) | II | Y | na |
13,393 | M | RC (48), CST (58) | I & II | Y | MMR IHC proficient and MSS |
14,963 | F | Hyperplastic polyp (69), BC (62) | 0 | Y | na |
19609a | F | CC (42), M (44), BC (57) | 0 | Y | MMR IHC proficient |
22,953 | F | BC (53) | II | Y | na |
24,789 | F | CC (43), RC (65), BC (72) | I & II | Y | MMR IHC proficient and MSS |
25,167 | M | CC (55) | I & II | Y | MMR IHC proficient |
5597 | M | Hyperplastic polyp (53/54), SC (55), KC (62) | 0 | Y | MMR IHC proficient |
8913 | F | Hyperplastic polyp (59), BC (61), TC (69) | 0 | Y | na |